Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

miR-1247-3p was downregulated in CRC resistant cells. by Dequan Wang (6007007)

Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells. by Dequan Wang (6007007)

Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment. by Richard Junior Zapata Dongo (17912565)

miR-1247-3p was downregulated in tissues of patients with CRC and was associated with prognosis and drug resistance. by Dequan Wang (6007007)

Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells. by Dequan Wang (6007007)

Data Sheet 1_Preclinical evidence and potential mechanisms of tanshinone ⅡA on cognitive function in animal models of Alzheimer’s disease: a systematic review and meta-analysis.doc... by Yuanhang Rong (19207540)

“…Risk of bias was evaluated following the Systematic Review Center for Laboratory Animal Experiments. The mean difference (MD) or standard mean difference (SMD) with 95% confidence intervals (CIs) were used to evaluate the effect of Tan ⅡA on cognitive function, neuropathology, neuroinflammation, oxidative stress, apoptosis, and neural/synaptic plasticity, with P < 0.05 considered a significant difference. …”

BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK^mutants. by Richard Junior Zapata Dongo (17912565)

HE staining results of cartilage tissue in different groups of rat PTOA (A: normal group, B: mild PTOA group, C: severe PTOA group). by Peng-fei Han (694841)

DIP grouping and aggregation system. by Chenxuan Zhu (22622476)

“…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β₁ + β₃ = −3.12). …”

DIP coding logic example. by Chenxuan Zhu (22622476)

“…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β₁ + β₃ = −3.12). …”

DIP pre-payment and provider behavior mechanism. by Chenxuan Zhu (22622476)

“…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β₁ + β₃ = −3.12). …”

a. Positive ion mode volcanic map (color and up-regulation correlation with differential metabolites) (A) Mild PTOA Group VS Severe PTOA Group (B) Mild PTOA Group VS Normal Group (... by Peng-fei Han (694841)

Table 1_Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway.docx by Yingchao Wu (2870927)

“…Existing therapeutic agents are generally accompanied by significant side effects. Here, we highlight Saikosaponin A (SSA), a promising natural metabolite characterized by low toxicity, demonstrating significant efficacy against breast cancer through the induction of cellular senescence.…”

Literature comparison. by Saravanan Manoharan (21273304)

“…To reduce labeling effort, we apply a Query by Committee-based active learning technique, significantly decreasing the required labeling effort by one-sixth. …”

Flow chart of proposed system. by Saravanan Manoharan (21273304)

“…To reduce labeling effort, we apply a Query by Committee-based active learning technique, significantly decreasing the required labeling effort by one-sixth. …”

Literature review. by Saravanan Manoharan (21273304)

“…To reduce labeling effort, we apply a Query by Committee-based active learning technique, significantly decreasing the required labeling effort by one-sixth. …”

IMU data and video synchronization. by Saravanan Manoharan (21273304)

“…To reduce labeling effort, we apply a Query by Committee-based active learning technique, significantly decreasing the required labeling effort by one-sixth. …”

Confusion matrix-punch classification. by Saravanan Manoharan (21273304)

“…To reduce labeling effort, we apply a Query by Committee-based active learning technique, significantly decreasing the required labeling effort by one-sixth. …”

¹⁷⁷Lu-Labeled Heterodimeric Agent with High Stability Targeting Neovascularization for Tumor Radioligand Therapy by Biao Yang (545048)

“…Radiopharmaceutical theranostics holds significant promise in tumor diagnosis and treatment, but suboptimal tumor uptake and retention remain a persistent limitation. …”